Xiaoqing Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Xiaoqing Guo has a total of 124 co-authors. Here are the top co-authors by number of shared publications:
- Nan Mei
Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USA
17 shared publications Ji-Eun Seo
Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration , Jefferson, AR 72079
15 shared publicationsXilin Li
Division of Genetic and Molecular Toxicology National Center for Toxicological Research, U.S. Food and Drug Administration Jefferson Arkansas USA
8 shared publicationsAisar H. Atrakchi
Center for Drug Evaluation and Research, U.S. Food and Drug Administration Silver Spring Maryland USA
6 shared publicationsNan Mei
National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, 72079, USA
6 shared publicationsRobert H. Heflich
Division of Genetic and Molecular Toxicology National Center for Toxicological Research, U.S. Food and Drug Administration Jefferson Arkansas USA
6 shared publications
Latest Publications
- 30 September 2026
- Published by Wiley in Environmental and Molecular Mutagenesis
- Vol. 67 (8-9) , e70082
DNA Damage and Micronucleus Induction by Small‐Molecule Nitrosamine Drug Impurities and Nitrosamine Drug Substance‐Related Impurities in HepaRG Cells
Nitrosamine drug impurities, including both small‐molecule nitrosamines and nitrosamine drug substance‐related impurities (NDSRIs), are members of a cohort of concern for pharmaceutical safety assessment. As the toxicity of most nitrosamine impurities requires metabolic activation by cytochrome P450 enzymes, this study used human HepaRG cells, which have metabolic activity similar to that of human hepatic cells, to evaluate methods for nitrosamine safety assessment. The genotoxicity of four small‐molecule nitrosamines, N‐ bis(2,2‐diethoxyethyl) nitrous amide (BDEA), N ‐nitrosodiphenylamine, N,N ‐nitroso‐ N ‐ethylaniline (NEPA), and 1‐methyl‐4‐nitrosopiperazine (MNP), and five NDSRIs, N ‐nitroso‐bumetanide, N ‐nitroso‐ciprofloxacin, N ‐nitroso‐dabigatran etexilate, N ‐nitroso‐desmethyl‐diphenhydramine, and N ‐nitroso‐sertraline, was evaluated in two‐dimensional (2D)/attached and three‐dimensional (3D)/spheroid HepaRG cell cultures using two high‐throughput genetic toxicity assays, the CometChip DNA damage assay and the flow‐cytometric micronucleus (MN) assay. These test substances exhibited a range of responses in other genotoxicity assays, including strong positive, negative, and inconclusive results. Following a 24‐h treatment, two NDSRIs, N ‐nitroso‐desmethyl‐diphenhydramine and N ‐nitroso‐sertraline, and two small‐molecule nitrosamines, BDEA and MNP, induced DNA damage, with the small‐molecule nitrosamines positive only in 3D HepaRG spheroids. MN formation was detected only in spheroids exposed to N ‐nitroso‐desmethyl‐diphenhydramine. Benchmark concentration (BMC) values derived from the DNA damage data were lower for the genotoxic NDSRIs compared to the genotoxic small‐molecule nitrosamines, which correlated with higher cytotoxicity for the NDSRIs. These results show that, while HepaRG spheroids were a more sensitive model for the hazard identification of small‐molecule nitrosamines, the responses produced by NDSRIs were more complex, with NDSRIs tested producing similar levels of DNA damage in 2D and 3D cultures and inducing MN formation only in 3D spheroids.
- 30 September 2026
- Published by Wiley in Environmental and Molecular Mutagenesis
- Vol. 67 (8-9) , e70082
DNA Damage and Micronucleus Induction by Small‐Molecule Nitrosamine Drug Impurities and Nitrosamine Drug Substance‐Related Impurities in HepaRG Cells
Nitrosamine drug impurities, including both small‐molecule nitrosamines and nitrosamine drug substance‐related impurities (NDSRIs), are members of a cohort of concern for pharmaceutical safety assessment. As the toxicity of most nitrosamine impurities requires metabolic activation by cytochrome P450 enzymes, this study used human HepaRG cells, which have metabolic activity similar to that of human hepatic cells, to evaluate methods for nitrosamine safety assessment. The genotoxicity of four small‐molecule nitrosamines, N‐ bis(2,2‐diethoxyethyl) nitrous amide (BDEA), N ‐nitrosodiphenylamine, N,N ‐nitroso‐ N ‐ethylaniline (NEPA), and 1‐methyl‐4‐nitrosopiperazine (MNP), and five NDSRIs, N ‐nitroso‐bumetanide, N ‐nitroso‐ciprofloxacin, N ‐nitroso‐dabigatran etexilate, N ‐nitroso‐desmethyl‐diphenhydramine, and N ‐nitroso‐sertraline, was evaluated in two‐dimensional (2D)/attached and three‐dimensional (3D)/spheroid HepaRG cell cultures using two high‐throughput genetic toxicity assays, the CometChip DNA damage assay and the flow‐cytometric micronucleus (MN) assay. These test substances exhibited a range of responses in other genotoxicity assays, including strong positive, negative, and inconclusive results. Following a 24‐h treatment, two NDSRIs, N ‐nitroso‐desmethyl‐diphenhydramine and N ‐nitroso‐sertraline, and two small‐molecule nitrosamines, BDEA and MNP, induced DNA damage, with the small‐molecule nitrosamines positive only in 3D HepaRG spheroids. MN formation was detected only in spheroids exposed to N ‐nitroso‐desmethyl‐diphenhydramine. Benchmark concentration (BMC) values derived from the DNA damage data were lower for the genotoxic NDSRIs compared to the genotoxic small‐molecule nitrosamines, which correlated with higher cytotoxicity for the NDSRIs. These results show that, while HepaRG spheroids were a more sensitive model for the hazard identification of small‐molecule nitrosamines, the responses produced by NDSRIs were more complex, with NDSRIs tested producing similar levels of DNA damage in 2D and 3D cultures and inducing MN formation only in 3D spheroids.
- Open Access
- 8 March 2026
- Published by Elsevier in NAM Journal
- Vol. 2, 100084
Mutagenicity of EAT-positive NDSRIs in HepaRG spheroids
- 8 March 2026
- Published by Elsevier in NAM Journal
- Vol. 2, 100084
Open AccessMutagenicity of EAT-positive NDSRIs in HepaRG spheroids
- 23 February 2026
- Published by Oxford University Press (OUP) in Mutagenesis
- Vol. 41 (4) , 175-188
Mutagenicity of N -nitroso-fluoxetine and N -nitroso-varenicline in human HepaRG cell models
Nitrosamine drug substance-related impurities (NDSRIs) have raised significant concern among the pharmaceutical industry and regulatory agencies, prompting a need to establish methods to determine the mutagenic risks associated with these substances. As human, metabolically competent HepaRG cells previously showed promise in evaluating the mutagenicity of a small-molecule nitrosamine impurity, N-nitroso-dimethylamine (NDMA), this study evaluated the suitability of HepaRG cells for mutagenesis assessment of NDSRIs. HepaRG cells, cultured in both two-dimensional (2D) and three-dimensional (3D) spheroid formats, were exposed to N-nitroso-fluoxetine and N-nitroso-varenicline for either 3 days or 14 days. DNA damage was evaluated using the comet assay, clastogenicity/aneugenicity was measured with the micronucleus (MN) assay, and mutagenesis was assessed using high-fidelity sequencing (HiFi-seq). N-Nitroso-fluoxetine and N-nitroso-varenicline were cytotoxic, produced DNA damage, and increased mutation frequency in both 2D and 3D HepaRG models. Both compounds increased MN formation only at the highest concentration in 3D spheroids after the 14-day exposure. Benchmark concentration (BMC) analysis indicated that, despite overlapping confidence intervals between 2D and 3D HepaRG cultures, in most instances BMC values tended to be lower in 3D than in 2D cultures after both 3-day and 14-day treatments. In addition, the 14-day treatments of both 2D and 3D HepaRG cultures with N-nitroso-fluoxetine resulted in higher levels of mutagenesis than the 3-day treatments, while 3-day and 14-day treatments with N-nitroso-varenicline produced similar mutagenesis responses. These findings demonstrate the feasibility of employing HepaRG cells with HiFi-seq as a mammalian cell assay for assessing NDSRI mutagenesis.
- 23 February 2026
- Published by Oxford University Press (OUP) in Mutagenesis
- Vol. 41 (4) , 175-188
Mutagenicity of N -nitroso-fluoxetine and N -nitroso-varenicline in human HepaRG cell models
Nitrosamine drug substance-related impurities (NDSRIs) have raised significant concern among the pharmaceutical industry and regulatory agencies, prompting a need to establish methods to determine the mutagenic risks associated with these substances. As human, metabolically competent HepaRG cells previously showed promise in evaluating the mutagenicity of a small-molecule nitrosamine impurity, N-nitroso-dimethylamine (NDMA), this study evaluated the suitability of HepaRG cells for mutagenesis assessment of NDSRIs. HepaRG cells, cultured in both two-dimensional (2D) and three-dimensional (3D) spheroid formats, were exposed to N-nitroso-fluoxetine and N-nitroso-varenicline for either 3 days or 14 days. DNA damage was evaluated using the comet assay, clastogenicity/aneugenicity was measured with the micronucleus (MN) assay, and mutagenesis was assessed using high-fidelity sequencing (HiFi-seq). N-Nitroso-fluoxetine and N-nitroso-varenicline were cytotoxic, produced DNA damage, and increased mutation frequency in both 2D and 3D HepaRG models. Both compounds increased MN formation only at the highest concentration in 3D spheroids after the 14-day exposure. Benchmark concentration (BMC) analysis indicated that, despite overlapping confidence intervals between 2D and 3D HepaRG cultures, in most instances BMC values tended to be lower in 3D than in 2D cultures after both 3-day and 14-day treatments. In addition, the 14-day treatments of both 2D and 3D HepaRG cultures with N-nitroso-fluoxetine resulted in higher levels of mutagenesis than the 3-day treatments, while 3-day and 14-day treatments with N-nitroso-varenicline produced similar mutagenesis responses. These findings demonstrate the feasibility of employing HepaRG cells with HiFi-seq as a mammalian cell assay for assessing NDSRI mutagenesis.
- 22 August 2025
- Published by Taylor & Francis in Journal of Environmental Science and Health, Part C
- Vol. 43 (4) , 333-355
Mutation accumulation following extended exposure of human HepaRG cells to a genotoxic carcinogen
Accurately evaluating chemical risk may benefit from the development of human-relevant models capable of capturing the effects of treatments that closely mimic real-world environmental and pharmaceutical exposures. Building on our previous work (Seo et al. Arch Toxicol 98:1919-1935),1 where cytotoxicity compromised mutation detection following short-term treatments, this study investigated mutation accumulation in both 2D and 3D HepaRG cultures following 7- and 14-day exposures with relatively non-cytotoxic N-nitrosodimethylamine (NDMA) concentrations. A multi-endpoint approach was employed to assess NDMA-induced DNA damage, micronucleus formation, and mutagenesis. Seven-day NDMA treatments were not cytotoxic but produced concentration-dependent increases in DNA damage and mutations. After 14 days of exposure, the highest NDMA concentrations produced no more than 30% cytotoxicity, and induced greater mutation frequencies compared to the 7-day exposures. Overall, the mutation frequencies induced by NDMA exhibited concentration- and treatment-duration-dependent relationships in both 2D and 3D HepaRG cultures, with notably higher mutation frequencies in 3D spheroids than in 2D cultures. Quantitative analysis by benchmark concentration (BMC) modeling demonstrated lower BMC values in 3D spheroids compared to their 2D counterparts. The predominant mutation in NDMA-treated cultures was T→C transition. These findings indicate the value of extended exposure periods for conducting in vitro genotoxicity testing in HepaRG cells.
- 22 August 2025
- Published by Taylor & Francis in Journal of Environmental Science and Health, Part C
- Vol. 43 (4) , 333-355
Mutation accumulation following extended exposure of human HepaRG cells to a genotoxic carcinogen
Accurately evaluating chemical risk may benefit from the development of human-relevant models capable of capturing the effects of treatments that closely mimic real-world environmental and pharmaceutical exposures. Building on our previous work (Seo et al. Arch Toxicol 98:1919-1935),1 where cytotoxicity compromised mutation detection following short-term treatments, this study investigated mutation accumulation in both 2D and 3D HepaRG cultures following 7- and 14-day exposures with relatively non-cytotoxic N-nitrosodimethylamine (NDMA) concentrations. A multi-endpoint approach was employed to assess NDMA-induced DNA damage, micronucleus formation, and mutagenesis. Seven-day NDMA treatments were not cytotoxic but produced concentration-dependent increases in DNA damage and mutations. After 14 days of exposure, the highest NDMA concentrations produced no more than 30% cytotoxicity, and induced greater mutation frequencies compared to the 7-day exposures. Overall, the mutation frequencies induced by NDMA exhibited concentration- and treatment-duration-dependent relationships in both 2D and 3D HepaRG cultures, with notably higher mutation frequencies in 3D spheroids than in 2D cultures. Quantitative analysis by benchmark concentration (BMC) modeling demonstrated lower BMC values in 3D spheroids compared to their 2D counterparts. The predominant mutation in NDMA-treated cultures was T→C transition. These findings indicate the value of extended exposure periods for conducting in vitro genotoxicity testing in HepaRG cells.
- 15 July 2025
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 162, 105906
Genotoxicity evaluation of ten nitrosamine drug substance-related impurities using 2D and 3D HepaRG cell models
- 15 July 2025
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 162, 105906
Genotoxicity evaluation of ten nitrosamine drug substance-related impurities using 2D and 3D HepaRG cell models
- 12 June 2025
- Published by Taylor & Francis in Journal of Environmental Science and Health, Part C
- Vol. 43 (3) , 1-26
Review of black cohosh-induced toxicity and adverse clinical effects
Black cohosh (Actaea racemosa L) has been utilized for centuries by Native Americans as a traditional herbal medicine. The rhizome and root extract from black cohosh (BCE) is one of the most popular herbal dietary supplements worldwide. Due to its claimed estrogen-like effects, contemporary uses of black cohosh products are primarily for alleviating menopausal and perimenopausal symptoms. However, recent studies indicate that BCE is not only ineffective for menopausal therapy, but also induces genotoxicity through an aneugenic mode of action (MoA). Adverse effects induced by BCE have been reported in humans, with many case studies documenting outcomes ranging from mild reactions to acute liver damage and even death. Consequently, concerns about the safety of BCE have emerged. There are more than 100 chemical constituents in black cohosh products, including triterpene glycosides (>40 chemicals), polyphenols (>20 chemicals), and nitrogenous compounds (>70 chemicals). Therefore, commercially available BCE products can differ markedly in composition, leading to the potential for variable bioactivities among these complex commercial products. This review presents the latest information on the toxicological effects of BCE from both in vivo and in vitro experiments and summarizes the adverse effects of BCE in human clinical trials.
- 12 June 2025
- Published by Taylor & Francis in Journal of Environmental Science and Health, Part C
- Vol. 43 (3) , 1-26
Review of black cohosh-induced toxicity and adverse clinical effects
Black cohosh (Actaea racemosa L) has been utilized for centuries by Native Americans as a traditional herbal medicine. The rhizome and root extract from black cohosh (BCE) is one of the most popular herbal dietary supplements worldwide. Due to its claimed estrogen-like effects, contemporary uses of black cohosh products are primarily for alleviating menopausal and perimenopausal symptoms. However, recent studies indicate that BCE is not only ineffective for menopausal therapy, but also induces genotoxicity through an aneugenic mode of action (MoA). Adverse effects induced by BCE have been reported in humans, with many case studies documenting outcomes ranging from mild reactions to acute liver damage and even death. Consequently, concerns about the safety of BCE have emerged. There are more than 100 chemical constituents in black cohosh products, including triterpene glycosides (>40 chemicals), polyphenols (>20 chemicals), and nitrogenous compounds (>70 chemicals). Therefore, commercially available BCE products can differ markedly in composition, leading to the potential for variable bioactivities among these complex commercial products. This review presents the latest information on the toxicological effects of BCE from both in vivo and in vitro experiments and summarizes the adverse effects of BCE in human clinical trials.
- 2 May 2025
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 416, 111538
Comparative DNA damage induced by eight nitrosamines in primary human and macaque hepatocytes
- 2 May 2025
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 416, 111538
Comparative DNA damage induced by eight nitrosamines in primary human and macaque hepatocytes
- 3 January 2025
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 206 (2) , 409-419
Integration of the rat liver micronucleus assay into a 28-day treatment protocol: testing the genotoxicity of 4 small-molecule nitrosamines with different carcinogenic potencies and tumor target specificities
Several potent carcinogenic nitrosamines, including N-nitrosodiethylamine (NDEA) and N-nitrosodimethylamine (NDMA), induce micronuclei in the micronucleated hepatocyte (MNHEP) assay but not in the micronucleated reticulocyte (MNRET) assay. However, the MNHEP assay is not as frequently used as the MNRET assay for evaluating in vivo genotoxicity. The present study evaluated MN formation in the liver of Big Blue transgenic rats exposed to 4 small-molecule nitrosamines, NDMA, N-nitrosodiisopropylamine (NDIPA), N-nitrosoethylisopropylamine (NEIPA), and N-nitrosomethylphenylamine (NMPA), using a repeat-dose protocol typically used for in vivo mutagenicity studies. NDMA is a potent liver carcinogen, whereas NDIPA and NEIPA are relatively weak liver carcinogens, and NMPA primarily produces esophageal tumors. Seven-week-old rats were treated with the nitrosamines for 28 consecutive days; liver was harvested 3 days after the last dose and used for conducting the flow-cytometry-based MNHEP assay. All 4 nitrosamines induced dose-dependent increases in %MNHEP and the magnitude of the responses correlated with their carcinogenicity in rat liver. These results indicate that the flow-cytometry-based MNHEP assay can be successfully integrated into 28-day repeat-dose studies, and that the MNHEP assay may be useful for evaluating the genotoxicity of nitrosamines that have different carcinogenic potencies and different tumor target specificities.
- 3 January 2025
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 206 (2) , 409-419
Integration of the rat liver micronucleus assay into a 28-day treatment protocol: testing the genotoxicity of 4 small-molecule nitrosamines with different carcinogenic potencies and tumor target specificities
Several potent carcinogenic nitrosamines, including N-nitrosodiethylamine (NDEA) and N-nitrosodimethylamine (NDMA), induce micronuclei in the micronucleated hepatocyte (MNHEP) assay but not in the micronucleated reticulocyte (MNRET) assay. However, the MNHEP assay is not as frequently used as the MNRET assay for evaluating in vivo genotoxicity. The present study evaluated MN formation in the liver of Big Blue transgenic rats exposed to 4 small-molecule nitrosamines, NDMA, N-nitrosodiisopropylamine (NDIPA), N-nitrosoethylisopropylamine (NEIPA), and N-nitrosomethylphenylamine (NMPA), using a repeat-dose protocol typically used for in vivo mutagenicity studies. NDMA is a potent liver carcinogen, whereas NDIPA and NEIPA are relatively weak liver carcinogens, and NMPA primarily produces esophageal tumors. Seven-week-old rats were treated with the nitrosamines for 28 consecutive days; liver was harvested 3 days after the last dose and used for conducting the flow-cytometry-based MNHEP assay. All 4 nitrosamines induced dose-dependent increases in %MNHEP and the magnitude of the responses correlated with their carcinogenicity in rat liver. These results indicate that the flow-cytometry-based MNHEP assay can be successfully integrated into 28-day repeat-dose studies, and that the MNHEP assay may be useful for evaluating the genotoxicity of nitrosamines that have different carcinogenic potencies and different tumor target specificities.
- 16 September 2024
- Published by Wiley in Current Protocols
- Vol. 4 (9) , e70015
Isolation and Cryopreservation of Primary Macaque Hepatocytes
Primary human hepatocytes (PHHs) are recognized as the "gold standard" for evaluating toxicity of various drugs or chemicals in vitro. However, due to their limited availability, primary hepatocytes isolated from rodents are more commonly used in various experimental studies than PHHs. However, bigger differences in drug metabolism were seen between humans and rats compared to those between human and non‐human primates. Here, we describe a method to isolate primary hepatocytes from the liver of rhesus macaques (Macaca mulatta, a species of Old‐World monkey) after in situ whole liver perfusion. Techniques for cryopreserving and recovering primary macaque hepatocytes (PMHs) are also described. Given the remarkable physiological and genetic similarity of non‐human primates to humans, PMHs isolated using this protocol may serve as a reliable surrogate of PHHs in toxicological research and preclinical studies. Published 2024. This article is a U.S. Government work and is in the public domain in the USA.Basic Protocol 1: In situ whole liver perfusionBasic Protocol 2: Primary macaque hepatocyte isolation and cell platingBasic Protocol 3: Cryopreservation and recovery of primary macaque hepatocytes
- 16 September 2024
- Published by Wiley in Current Protocols
- Vol. 4 (9) , e70015
Isolation and Cryopreservation of Primary Macaque Hepatocytes
Primary human hepatocytes (PHHs) are recognized as the "gold standard" for evaluating toxicity of various drugs or chemicals in vitro. However, due to their limited availability, primary hepatocytes isolated from rodents are more commonly used in various experimental studies than PHHs. However, bigger differences in drug metabolism were seen between humans and rats compared to those between human and non‐human primates. Here, we describe a method to isolate primary hepatocytes from the liver of rhesus macaques (Macaca mulatta, a species of Old‐World monkey) after in situ whole liver perfusion. Techniques for cryopreserving and recovering primary macaque hepatocytes (PMHs) are also described. Given the remarkable physiological and genetic similarity of non‐human primates to humans, PMHs isolated using this protocol may serve as a reliable surrogate of PHHs in toxicological research and preclinical studies. Published 2024. This article is a U.S. Government work and is in the public domain in the USA.Basic Protocol 1: In situ whole liver perfusionBasic Protocol 2: Primary macaque hepatocyte isolation and cell platingBasic Protocol 3: Cryopreservation and recovery of primary macaque hepatocytes
- Open Access
- 7 April 2024
- Published by Springer Nature in Archives of Toxicology
- Vol. 98 (6) , 1919-1935
Evaluating the mutagenicity of N-nitrosodimethylamine in 2D and 3D HepaRG cell cultures using error-corrected next generation sequencing
Human liver-derived metabolically competent HepaRG cells have been successfully employed in both two-dimensional (2D) and 3D spheroid formats for performing the comet assay and micronucleus (MN) assay. In the present study, we have investigated expanding the genotoxicity endpoints evaluated in HepaRG cells by detecting mutagenesis using two error-corrected next generation sequencing (ecNGS) technologies, Duplex Sequencing (DS) and High-Fidelity (HiFi) Sequencing. Both HepaRG 2D cells and 3D spheroids were exposed for 72 h to N-nitrosodimethylamine (NDMA), followed by an additional incubation for the fixation of induced mutations. NDMA-induced DNA damage, chromosomal damage, and mutagenesis were determined using the comet assay, MN assay, and ecNGS, respectively. The 72-h treatment with NDMA resulted in concentration-dependent increases in cytotoxicity, DNA damage, MN formation, and mutation frequency in both 2D and 3D cultures, with greater responses observed in the 3D spheroids compared to 2D cells. The mutational spectrum analysis showed that NDMA induced predominantly A:T → G:C transitions, along with a lower frequency of G:C → A:T transitions, and exhibited a different trinucleotide signature relative to the negative control. These results demonstrate that the HepaRG 2D cells and 3D spheroid models can be used for mutagenesis assessment using both DS and HiFi Sequencing, with the caveat that severe cytotoxic concentrations should be avoided when conducting DS. With further validation, the HepaRG 2D/3D system may become a powerful human-based metabolically competent platform for genotoxicity testing.
- 7 April 2024
- Published by Springer Nature in Archives of Toxicology
- Vol. 98 (6) , 1919-1935
Open AccessEvaluating the mutagenicity of N-nitrosodimethylamine in 2D and 3D HepaRG cell cultures using error-corrected next generation sequencing
Human liver-derived metabolically competent HepaRG cells have been successfully employed in both two-dimensional (2D) and 3D spheroid formats for performing the comet assay and micronucleus (MN) assay. In the present study, we have investigated expanding the genotoxicity endpoints evaluated in HepaRG cells by detecting mutagenesis using two error-corrected next generation sequencing (ecNGS) technologies, Duplex Sequencing (DS) and High-Fidelity (HiFi) Sequencing. Both HepaRG 2D cells and 3D spheroids were exposed for 72 h to N-nitrosodimethylamine (NDMA), followed by an additional incubation for the fixation of induced mutations. NDMA-induced DNA damage, chromosomal damage, and mutagenesis were determined using the comet assay, MN assay, and ecNGS, respectively. The 72-h treatment with NDMA resulted in concentration-dependent increases in cytotoxicity, DNA damage, MN formation, and mutation frequency in both 2D and 3D cultures, with greater responses observed in the 3D spheroids compared to 2D cells. The mutational spectrum analysis showed that NDMA induced predominantly A:T → G:C transitions, along with a lower frequency of G:C → A:T transitions, and exhibited a different trinucleotide signature relative to the negative control. These results demonstrate that the HepaRG 2D cells and 3D spheroid models can be used for mutagenesis assessment using both DS and HiFi Sequencing, with the caveat that severe cytotoxic concentrations should be avoided when conducting DS. With further validation, the HepaRG 2D/3D system may become a powerful human-based metabolically competent platform for genotoxicity testing.